Cita APA

Ma, C., Fedorak, R., Kaplan, G. G., Dieleman, L. A., Devlin, S., Stern, N., . . . Panaccione, R. (2018). A106 USTEKINUMAB IS EFFECTIVE FOR MAINTAINING CLINICAL RESPONSE IN REFRACTORY MODERATE-TO-SEVERE CROHN’S DISEASE: A MULTICENTRE COHORT STUDY. J Can Assoc Gastroenterol.

Chicago Style Citation

Ma, C., et al. "A106 USTEKINUMAB IS EFFECTIVE FOR MAINTAINING CLINICAL RESPONSE IN REFRACTORY MODERATE-TO-SEVERE CROHN’S DISEASE: A MULTICENTRE COHORT STUDY." J Can Assoc Gastroenterol 2018.

Cita MLA

Ma, C., et al. "A106 USTEKINUMAB IS EFFECTIVE FOR MAINTAINING CLINICAL RESPONSE IN REFRACTORY MODERATE-TO-SEVERE CROHN’S DISEASE: A MULTICENTRE COHORT STUDY." J Can Assoc Gastroenterol 2018.